Transarterial Radioembolization Slows Progression of CRC With Liver Mets Small increase in median PFS when combined with second-line chemotherapy Sep 21, 2021
Androgen-Targeting Combos Show Promise in Prostate Cancer Trials extend survival in hormone-sensitive disease Sep 21, 2021
Bifunctional Protein Shows Promise in HPV-Related Cancers Objective responses in 28% of pretreated patients, durable in most cases Sep 20, 2021
Sunitinib Effective in Very Rare Neuroendocrine Tumor The TKI boosted PFS in patients with malignant pheochromocytoma and paraganglioma Sep 20, 2021
Chemo Plus Keytruda Boosts Overall Survival in Advanced TNBC KEYNOTE-355 regimen offers "transformative treatment" in PD-L1-positive disease, expert says Sep 20, 2021
ADC Makes a Case for Role in Metastatic HER2-Positive Breast Cancer Improved progression-free survival in previously treated disease with trastuzumab duocarmazine Sep 20, 2021
Combo Treatment Extends Survival in HR+HER2- Advanced Breast Cancer MONALEESA-2's "big message": 12.5-month boost in median OS with ribociclib-aromatase inhibitor Sep 19, 2021
Another Possible Option for HER2-Mutated Non-Small Cell Lung Cancer More than half of patients responded to antibody-drug conjugate targeting HER2 Sep 19, 2021
Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanoma Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
Practice-Changing Study in Advanced Cervical Cancer Improved PFS, OS with pembrolizumab and chemo with or without bevacizumab Sep 18, 2021
Trastuzumab Deruxtecan: New Standard of Care in Pretreated, Advanced Breast Cancer? DESTINY-Breast03 turns in "absolutely startling" PFS in HER2-positive metastatic disease Sep 18, 2021
Extended Letrozole Reduced Recurrence Risk in Postmenopausal Breast Cancer 5 years of the aromatase inhibitor improved disease-free survival vs 2-3 years Sep 17, 2021
As Safety Data on HPV Vaccine Improves, Why Is Parental Hesitancy Going Up? Findings suggest "an urgent need" to combat sentiment, restore confidence, researchers say Sep 17, 2021
Rechallenge With PARP Inhibitor Slows Relapsed Ovarian Cancer Benefits platinum-sensitive disease irrespective of BRCA, homologous repair status, study showed Sep 17, 2021
Some Reassurance on Cancer Risk With RAI Therapy for Hyperthyroidism No overall risk increase in large meta-analysis, but higher risk seen for thyroid cancer Sep 17, 2021
Longer Hydroxyurea Tied to Improved Sickle-Cell Heart Issues Kids on treatment for less than 1 year had a significantly greater prevalence of LV dilation Sep 16, 2021
AI's Help in Colonoscopy Led to Fewer Missed Adenomas U.S. study explores benefit of newer technology in colon cancer screening, surveillance Sep 15, 2021
More Help on the Way for Lung Cancers With Exon 20 Mutations? Early trials of DZD9008 demonstrated responses in over a third of patients Sep 15, 2021
Cancer Vaccine May Boost Anti-EGFR Efficacy in Non-Small Cell Lung Cancer More than 90% disease control rate, hint of improved PFS in pilot trial Sep 14, 2021
Novel ADC Promising in Certain Non-Squamous Lung Cancers Response rate topped 50% in patients with EGFR wild-type tumors and high MET expression Sep 14, 2021
Stanley Tucci's Tongue Cancer The Oscar-nominated actor opens up about his private battle Sep 13, 2021
More Data in Support of Surgery for Malignant Pleural Mesothelioma Six-month improvement in overall survival with surgery plus chemotherapy versus chemo alone Sep 13, 2021
Meta-Analysis Confirms Benefits of Low-Dose CT Screening for Lung Cancer LDCT associated with a 16% relative reduction in mortality versus no screening Sep 13, 2021
Best Way to Recover Urinary Continence After Prostatectomy? Nerve-sparing prostatectomy, not rehab or duloxetine, most important factor Sep 13, 2021
Which Prostate Biopsy Is Best: Transrectal or Transperineal? Advocates for one may face uphill battle, debate at AUA meeting suggests Sep 13, 2021
Immuno-Oncology Combo Active in Recurrent EGFR/ALK Positive NSCLC Responses in 42% of EGFR group, limited activity in ALK-rearranged lung cancer Sep 12, 2021
Triplet Therapy Proves Safe in Resectable Malignant Pleural Mesothelioma Atezolizumab add-on offers promising outcomes in phase I trial Sep 12, 2021
Plant-Based Diet Tied to Better Urological Health in Men "Eat more plants for your prostate and your erections Sep 12, 2021
Durable Response with Immunotherapy Combos in NSCLC with Brain Metastases Analysis of CheckMate 9LA data and phase II study from Spain offer hope in advanced disease Sep 12, 2021
Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancer Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
9/11 Responders Face Higher Risk of Multiple Cancers Longer follow-up sheds light on the long-term consequences of exposure to disaster site Sep 10, 2021
Durable Responses With IL-15 Superagonist in Early Bladder Cancer Addition of N-803 led to better responses in BCG-unresponsive disease Sep 10, 2021
Dual Immunotherapy Boosts Survival in Metastatic NSCLC Benefit with durvalumab-tremelimumab may vary by PD-L1 expression, histology Sep 10, 2021
Cancer Patients, COVID-19, and Long-Term Effects Preventing COVID sequelae can minimize disruption of cancer care, European study finds Sep 09, 2021
Study Sheds Light on Physician-Assisted Suicide in Lung Cancer Patients Patients often did not consult with radiation or medical oncologists Sep 09, 2021
Second-Line Combo Fails to Improve Survival in SCLC No OS difference, but lurbinectedin-doxorubicin was less toxic than standard chemotherapy options Sep 09, 2021
Life Expectancy Still Lower for Blood or Marrow Transplant Recipients Although late mortality has decreased over the past 40 years Sep 09, 2021
Cough, Cancer, PTSD: Two Decades of World Trade Center Studies Research has revealed the fallout of response to a crisis Sep 09, 2021
High Response Rate in Non-Small Cell Lung Cancer With RET Inhibitor Responses in 66-80% of patients from China confirm activity of pralsetinib Sep 09, 2021
TROP2 Antibody-Drug Conjugate Shows Promise in Lung Cancer Disease control observed in over two-thirds of patients at selected dose Sep 08, 2021
